Salīdzināt metodes
Apskatiet izvēlētās metodes blakus; rindas, kas atšķiras, ir izceltas.
| Adaptīvā klīnisko pētījumu dizains× | Secvenču / grupu secīgā plānojums× | |
|---|---|---|
| Nozare | Eksperimentu plānošana | Eksperimentu plānošana |
| Saime | Hypothesis test | Hypothesis test |
| Izcelsmes gads≠ | 1994 | 1979 |
| Autors≠ | Bauer & Köhne | O'Brien & Fleming; Pocock; Lan & DeMets |
| Tips≠ | Adaptive hypothesis test with interim analyses | Adaptive stopping trial design |
| Pirmavots≠ | Bauer, P. & Köhne, K. (1994). Evaluation of Experiments with Adaptive Interim Analyses. Biometrics, 50(4), 1029–1041. DOI ↗ | O'Brien, P.C. & Fleming, T.R. (1979). A Multiple Testing Procedure for Clinical Trials. Biometrics, 35(3), 549–556. DOI ↗ |
| Citi nosaukumi≠ | adaptive design, group sequential design, sample size re-estimation, platform trial | group sequential design, adaptive stopping design, Ardışık Deneme Tasarımı (Sequential / Group Sequential) |
| Saistītās | 3 | 3 |
| Kopsavilkums≠ | Adaptive clinical trial design is a flexible experimental framework, formalised by Bauer and Köhne in 1994, in which pre-specified rules allow the trial to be modified mid-course — adjusting sample size, treatment arms, or randomisation ratios — based on accumulating interim data while rigorously controlling the Type I error rate. | Sequential and group sequential trial designs allow a study to be stopped early — or continued — based on interim analyses conducted as data accumulate. The core framework was formalised by O'Brien and Fleming in 1979 and extended by Lan and DeMets's alpha-spending approach, and it controls the overall Type I error rate across all planned looks by pre-specifying both efficacy and futility boundaries before enrolment begins. |
| ScholarGateDatu kopa ↗ |
|
|